Disclosure Information

Declaration of Disclosure and Conflicts of Interest

It is the policy of AACE to ensure balance, independence, objectivity, and scientific rigor in all of its CME activities. Presentation content may include discussion of an unlabeled use of a commercial product or an investigational use of a product not yet approved for any purpose. AACE requires that participating faculty disclose to the audience any product(s) and its use(s) discussed in the educational activity that are unapproved/unlabeled for the use by the FDA or still considered investigational in nature.

Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships. “Relevant financial relationships” are financial relationships in any amount occurring within the past 12 months that create a conflict of interest. AACE requires speakers, faculty, CME Committee, and other individuals who are in a position to control the content of this educational activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly evaluated by AACE for fair balance, scientific objectivity of studies mentioned in the presentation, and educational materials used as basis for content, and appropriateness of patient care recommendations.

The intent of this disclosure is not to prevent a speaker with commercial affiliations from presenting, but rather to provide learners with information from which they may make their own judgments. Informed learners are the final safeguards in assuring that a CME activity is independent from commercial influence.

AACE has reviewed all disclosures and resolved or managed all identified conflicts of interest for this educational activity, as applicable.


CME Accreditation Committee Disclosures

 

Commercial Interest

What Was Recieved

For What Role

Myriam Allende-Vigo
MD, MBA, FACP, FACE

1.Merck

1.Honorarium

1.Advisor

Joshua I. Barzilay
MD, FACE

1.Abbvie
2.Bristol Myers Squibb
3.Merck
4.Pfizer
5.Sanofi
6.Teva

1.Dividends
2.Dividends
3.Dividends
4.Dividends
5.Dividends
6.Dividends

1.Part of my IRA
2.Part of my IRA
3.Part of my IRA
4.Part of my IRA
5.Part of my IRA
6.Part of my IRA

Tamis Bright, MD

1.Southwest ENT

1.Salary

1.Husband`s work

Philip Raskin
MD, FACE

1.Amylin Pharmaceuticals
2.Boehringer-Ingelheim
Pharmaceuticals
3.Gan & Lee Pharmaceuticals
4.Intarcia
5.Reata Pharmaceuticals

1.Research Grant
2.Research Grant

3.Research Grant
4.Consulting Fees
5.Consulting Fees

1.Independent Contractor
2.Independent Contractor

3.Independent Contractor
4.Advisory Committee
5.Consultant

Nothing to Disclose
Ricardo Correa, MD
Diane Donegan, MBChB
Phillip D.K. Lee, MD, FACE
Jad Sfeir, MD, FACP
Jagdeesh Ullal, MD, FACE, ECNU
Rong Mei Zhang, MD


Program Committee Disclosures

 

Commercial Interest

What Was Recieved

For What Role

*Mark A. Lupo
MD, FACE, ECNU

Program Committee,
Faculty

1.AbbVie
2.Eisai
3.Genzyme
4.Rosetta
5.Pathway Genomics
6.Veracyte

1.Honorarium
2.Honorarium
3.Honorarium
4.Honorarium
5.Honorarium
6.Research Funds

1.Speaker
2.Speaker
3.Speaker
4.Advisor
5.Research
6.Research

*J. Woody Sistrunk
MD, FACE, ECNU

Program Committee,
Faculty

1.Interpace Diagnostics
2.Rosetta Genomics

1.Research Support
2.Honorarium

1. Study Participation
2.Consultant

Nothing to Disclose
*Devaprabu Abraham, MD, MRCP, ECNU, FACE, Program Chair, Faculty


Faculty Disclosures

 

Commercial Interest

What Was Recieved

For What Role

*Mark A. Lupo
MD, FACE, ECNU

Program Committee,
Faculty

1.AbbVie
2.Eisai
3.Genzyme
4.Rosetta
5.Pathway Genomics
6.Veracyte

1.Honorarium
2.Honorarium
3.Honorarium
4.Honorarium
5.Honorarium
6.Research Funds

1.Speaker
2.Speaker
3.Speaker
4.Advisor
5.Research
6.Research

*J. Woody Sistrunk
MD, FACE, ECNU

Program Committee,
Faculty

1.Interpace Diagnostics
2.Rosetta Genomics

1.Research Support
2.Honorarium

1. Study Participation
2.Consultant

Alex Tessnow
MD, MBA, FACE, ECNU

1.Akrimax Pharmaceuticals
2.Spectrix Therapeutics

1.Research Grant
2.Honorarium

1.Principle Investigator
2.Advisor

Nothing to Disclose
*Devaprabu Abraham, MD, MRCP, ECNU, FACE, Program Chair, Faculty
Debbie Margulies, MD, FACE, ECNU, Faculty


Sonographer Faculty Disclosures

 

Commercial Interest

What Was Recieved

For What Role

Kevin R. Rooker
RT®, RDMS, RVT
Faculty

1.CIVCO

1.Salary

1.Employee

Emily Smith
BS, RDMS, RVT
Faculty

1.CIVCO

1.Salary

1.Employee

Nothing to Disclose
L. Jackie Kaddatz, RDMS


*designates a member of both faculty and program committee


Accreditation Statement

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.